The Latest Cardiac and Vascular News
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it is working with Mayo Clinic in a preclinical study about use of telestenting. Telestenting, or the remote robotic treatment for percutaneous coronary intervention (PCI), may enable physicians to conduct procedures from virtually any location, […]
CAMBRIDGE, England, January 3, 2018 /PRNewswire/ — Article in JACC: Basic to Translational Science Validates Feasibility and Unique Potential of LBS to Detect Biomarkers for Coronary Artery Disease PlaqueTec today announced the publication of the first peer-reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System (TM) (LBS) […]
DURHAM, N.C.–(BUSINESS WIRE)– Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company has appointed Carl J. St. Bernard as president and chief executive officer. St. Bernard has a long track record growing new and established businesses in pharmaceuticals, consumer health products, […]
MILFORD, Mass.–(BUSINESS WIRE)– RenalGuard Solutions, Inc., a medical device company focused on innovative technologies for the cardiac and vascular markets, today reported positive results from a first-in-man feasibility study focusing on a novel use of the RenalGuard System® to manage fluids during diuretic therapy in congestive heart failure patients suffering from fluid […]
SAO PAULO, Dec. 22, 2017 /PRNewswire/ — On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo, Brazil. After Chile and Argentina, Brazil becomes the third Latin American country to apply the valve of Venus Medtech (Hangzhou) Inc. It also marks […]
Privately-held Corvia Medical said its investigational transcatheter structural heart device to treat heart failure has demonstrated success in reducing exercise pulmonary capillary wedge pressure in trial patients. This morning, the company said its device, called the Interatrial Shunt Device (IASD) significantly reduced PCWP at one month compared to control. Data was presented at the 2017 […]
MONMOUTH JUNCTION, N.J., Dec. 21, 2017 /PRNewswire/ — CytoSorbents (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that the U.S. Food and Drug Administration (FDA) has granted approval of its REFRESH 2 Investigational Device Exemption […]
NEW YORK and MELBOURNE, Australia, Dec. 21, 2017 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its novel mesenchymal precursor cell (MPC) therapy in the treatment of heart failure patients with left ventricular […]
by Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) Marriage is the age old punch line to bad jokes about dying early, before your time. But new studies indicate that, for some, marriage actually extends life and improves outcomes! The study, by Arshed Quyyumi, of Emory University in Atlanta reports that heart disease […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc.(NYSE American: CVRS), a leading developer of precision vascular robotics, announced today the first commercial installation of a CorPath GRX System outside of the United States. The system was purchased by the Apex Heart Institute in Ahmedabad, India, a state of the art cardiology center. […]
